Myriad Gene Patent Case May Go To Supreme Court After Federal Circuit Backs Firm
This article was originally published in The Pink Sheet Daily
Executive Summary
A Federal Circuit panel again rules that Myriad Genetics’ patents covering BRCA genes isolated from the body are patent-eligible; the ACLU may request review by the full court or file a petition with the Supreme Court.